CNSX:TRULPharmaceuticals
The Bull Case For Trulieve Cannabis (CNSX:TRUL) Could Change Following Shelf Registration and Q2 Results
Trulieve Cannabis recently reported its second quarter 2025 results, showing sales of US$302.09 million and a net loss of US$13.78 million, alongside the filing of a US$55.5 million shelf registration for subordinate voting shares.
Management also issued third quarter guidance, anticipating a mid-single digit sequential revenue decline in line with historical seasonal trends, while the shelf registration suggests possible share dilution ahead.
Given the new shelf registration filing, we'll...